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Abstract
Objective To assess whether a weight management intervention for pregnant women with obesity was effective in reducing
body mass index (BMI) 12 months after giving birth.
Methods Pragmatic, cluster randomised controlled trial (RCT) with embedded cost-effectiveness analysis. 598 women with
a BMI of ≥30 kg/m2 (between 12 and 20 weeks gestation) were recruited from 20 secondary care maternity units in England
and Wales. BMI at 12 months postpartum was the primary outcome. A range of clinical and behavioural secondary
outcomes were examined.
Interventions Women attending maternity units randomised to intervention were invited to a weekly weight management
group, which combined expertise from a commercial weight loss programme with clinical advice from midwives. Both
intervention and control participants received usual care and leaflets on diet and physical activity in pregnancy.
Results Mean (SD) BMI at 12 months postpartum was 36.0 kg/m2 (5.2) in the control group, and 37.5 kg/m2 (6.7) in the
intervention group. After adjustment for baseline BMI, the intervention effect was −0.02 (95% CI −0.04 to 0.01). The
intervention group had an improved healthy eating score (3.08, 95% CI 0.16 to 6.00, p < 0.04), improved fibre score (3.22,
1.07 to 5.37, p < 0.01) and lower levels of risky drinking at 12 months postpartum compared to the control group (OR 0.45,
0.27 to 0.74, p < 0.002). The net incremental monetary benefit was not statistically significantly different between arms,
although the probability of the intervention being cost-effective was above 60%, at policy-relevant thresholds.
Conclusions There was no significant difference between groups on the primary outcome of BMI at 12 months. Analyses of
secondary outcomes indicated improved healthy eating and lower levels of risky drinking.
Trial registration: Current Controlled Trials ISRCTN25260464.
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Around a third to a half of pregnant women in the United
States (US), United Kingdom (UK) and Australia are
overweight or obese [1–3]. A significant number of
women (20–40%) have higher pregnancy weight gain
than is recommended [4, 5] which is associated with child
obesity [6, 7]. Many women gain weight during preg-
nancy which they subsequently retain, thus contributing
to the development of overweight and obesity [8–10].
Maternal obesity has been linked to increased healthcare
costs and risk of complications during pregnancy and
birth [11, 12].
A meta-analysis indicated that diet and physical
activity interventions reduced gestational weight gain
(GWG) [13]. Postpartum lifestyle interventions have also
been shown to achieve weight loss [14, 15]. Many studies
evaluating interventions for GWG or weight loss post-
partum have methodological problems, including issues
with randomisation, fidelity, retention, lack of theory and
no assessment of cost effectiveness [16–18]. This study,
building on a successful feasibility study [19] sought to
address some of the shortcomings of previous studies.
The primary study objective was to assess whether a
theory-based weight management intervention for pregnant
women with obesity, which starts during pregnancy and
continues into the postpartum period, was effective in
reducing women’s body mass index (BMI) 12 months after
giving birth. Secondary objectives were to examine the
impact of the intervention on pregnancy weight gain;
complications (during pregnancy and postnatally); diet;
physical activity; health-related quality of life; mental
health; breast feeding and child weight gain.
Methods
Trial design
This study was a non-blinded, cluster randomised trial of
the healthy eating and lifestyle in pregnancy (HELP)
intervention, with a concurrent process and health eco-
nomic evaluation. This was a pragmatic trial as we
recruited patients who would receive the intervention if it
were usual care, the intervention was delivered in a usual
care setting, there was some flexibility in how the inter-
vention was delivered and it was not possible to blind
participants or recruiters. The study took place in Eng-
land and Wales between February 2011 and June 2014.
Twenty maternity units were randomised in a 1:1 ratio
between intervention and control arms. Control centre
participants received usual National Health Service
(NHS) care and were given leaflets on healthy eating and
exercise during pregnancy. In addition to usual care and
the leaflets, intervention centre participants were also
offered the HELP intervention. Participants were fol-
lowed up at 36 weeks gestation and 6 weeks, 6 months
and 12 months postpartum. The study protocol has been
published, and a summary of the methods is given
below [20].
Centres and participants
After email contact from the study team, 20 maternity units
were confirmed as sites (Fig. 1). Units were chosen to include
a variety of demographic profiles including proportion of non-
white ethnicities (3–64%; mean 17.8%), proportion of women
with BMI > 30 (7–24%; mean 18.5%) and size of unit (births
per annum) (1600–8300; mean 4557).
Recruitment and written informed consent occurred after
site randomisation. Pregnant women aged 18 years or older
with a BMI ≥ 30 kg/m2 were approached opportunistically at
their earliest antenatal appointment (between 12 and
20 weeks gestation) by NHS midwives or researchers and
provided with information about the study. Midwives/
researchers approaching and recruiting women were not
involved in delivering the intervention.
Study intervention
The intervention provided support to enhance motivation
and equip women with knowledge and skills to enable
them to make healthier choices and manage their weight
during pregnancy and postpartum [20]. The intervention
targeted healthy eating (Slimming World “Extra Easy”
programme which follows UK government recommen-
dations) and physical activity (pedometer and walking
programme with step targets set and reviewed in group)
and included theory-based behaviour change techniques
(from Control Theory and Social Cognitive Theory)
shown to be efficacious in changing weight-related
behaviours [21–24].
Participants attending intervention units were invited
to attend free, weekly, 1.5 hour weight management
group sessions from recruitment until 6 weeks post-
partum (i.e. a maximum of 36 sessions depending when
they were recruited and gestation). Groups were held in
NHS antenatal clinics and run jointly by a NHS midwife
and a Slimming World (SW) consultant. At 6 weeks
postpartum women received one voucher for a free SW
session at a ‘regular’ community group. The Intervention
Midwife also telephoned them at 3 and 6 months post-
partum in order to provide longer-term support and dis-
cuss weight, healthy eating, physical activity and barriers
to success. Further details of the intervention content are
published elsewhere [20].
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Participants recruited and baseline completed (n = 
298)
Clusters lost to follow-up: n=0 (0%) 
Clusters completed follow-up: n=10 (100%) 
Participants full / part complete follow-up: n=280 (95.2%)  
Participants withdrawn / potential withdrawals: n=7 (2.4%) 
Lost to follow-up: n=7 (2.4%) 
- Miscarriage: n= 3 
- Unknown: n = 3 








team due to 
ineligibility 
(n=4)
Eligible participants included in baseline analysis (n = 
294, median per cluster 29.5, range 26-32)
HELP CONSORT Flow Diagram
Sites assessed for eligibility (n = 33)
Clusters randomised (n = 20)
Sites withdrawn (n = 3) 
Sites declined by study team (n=4) 
Sites ineligible (n=3) 
Confirmed as final back-up sites (n=3) 
Intervention sites / clusters (n = 10) Control sites / clusters (n = 10) 
Participants assessed for eligibility (n = 936) Participants assessed for eligibility (n = 575) 
Participants recruited and baseline completed (n = 307) 
Follow-up at 36 
weeks gestation 
Clusters lost to follow-up: n=0 (0%) 
Clusters completed follow-up: n=10 (100%) 
Participants full / part complete follow-up: n=212 (69.7%)  
Participants withdrawn / potential withdrawals: n=30 (9.9%) 
Lost to follow-up: n = 62 (20.4%) 
- Unable to contact: n = 23 
- Participant choice: n = 17 
- Early birth: n = 13 
- Missed by site: n = 7 
- No recruitment information from site: n = 1 
- Participant moved: n = 1 
Clusters lost to follow-up: n=0 (0%) 
Clusters completed follow-up: n=10 (100%) 
Participants full / part complete follow-up: n = 262 (89.1%) 
Participants withdrawn / potential withdrawals: n=14 (4.8%) 
Lost to follow-up: n = 18 (6.1%) 
- Unable to contact: n = 8 
- Participant choice: n = 4 
- Early birth: n = 4 
- Missed by site: n = 1 
- SAE = 1 
Clusters lost to follow-up: n=0 (0%) 
Clusters completed follow-up: n=10 (100%) 
Participants full / part complete follow-up: n=285 (93.8%)  
Participants withdrawn / potential withdrawals: n=11 (3.6%) 
Lost to follow-up: n=8 (2.6%) 
- Miscarriage: n= 1 
- Unknown: n = 7 
Postbirth CRF 
(completed 
following birth of 
baby) 
Eligible participants included in baseline analysis (n = 304, 
median per cluster 31, range 20-36)
Follow-up at 6 
weeks 
postpartum 
Follow-up at 6 
months 
postpartum 
Follow-up at 12 
months 
postpartum 
Clusters excluded from analysis: n=0 (0%) 
Clusters included in analysis: n=10 (100%) 
Participants included in primary outcome analysis: n=203 (66.7%)  
Participants excluded from analysis: n=11 (3.6%) 
- Reason 1: n = ? 
- Reason 2: n = ? 
Clusters excluded from analysis: n=0 (0%) 
Clusters included in analysis: n=10 (100%) 
Participants included in primary outcome analysis: n=245 (83.3%)  
Participants withdrawn / potential withdrawals: n=5 (1.7%) 
- Reason 1: n = ? 
- Reason 2: n = ? 
Clusters lost to follow-up: n=0 (0%) 
Clusters completed follow-up: n=10 (100%) 
Participants full / part complete follow-up: n=222 (73.0%)  
Participants withdrawn / potential withdrawals: n=40 (13.2%) 
Lost to follow-up: n = 42 (13.8%) 
- Unable to contact: n = 31 
- Participant choice: n = 4 
- Participant moved: n = 2 
- SAE: n = 2 
- No recruitment information from site: n = 1 
- Missed by site: n = 1 
- Study team error: n =1 
Clusters lost to follow-up: n=0 (0%) 
Clusters completed follow-up: n=10 (100%) 
Participants full / part complete follow-up: n=251 (85.4%)  
Participants withdrawn / potential withdrawals: n=17 (5.8%) 
Lost to follow-up: n = 26 (8.8%) 
- Site issue: n = 13 
- Unable to contact: n = 8 
- SAE: n = 2 
- Participant choice: n = 1 
- Participant moved: n = 1 




Clusters lost to follow-up: n=0 (0%) 
Clusters completed follow-up: n=10 (100%) 
Participants full / part complete follow-up: n=215 (70.7%)  
Participants withdrawn / potential withdrawals: n=45 (14.8%) 
Lost to follow-up: n = 44 (14.5%) 
- Unable to contact: n = 28 
- Site issue: n = 10 
- Participant choice: n = 3 
- Participant moved: n = 2 
- SAE: n = 1 
Clusters lost to follow-up: n=0 (0%) 
Clusters completed follow-up: n=10 (100%) 
Participants full / part complete follow-up: n=250 (85.0%)  
Participants withdrawn / potential withdrawals: n=17 (5.8%) 
Lost to follow-up: n = 27 (9.2%) 
- Unable to contact: n = 14 
- Site issue: n = 8 
- Participant choice: n = 4 
- Unknown: n = 1 
Clusters lost to follow-up: n=0 (0%) 
Clusters completed follow-up: n=10 (100%) 
Participants full / part complete follow-up: n=214 (70.4%)  
Participants withdrawn / potential withdrawals: n=45 (14.8%) 
Lost to follow-up: n = 45 (14.8%) 
- Unable to contact: n = 37 
- Site issue: n = 3 
- Participant choice: n = 2 
- Participant moved: n = 2 
- Unknown: n = 1 
Clusters lost to follow-up: n=0 (0%) 
Clusters completed follow-up: n=10 (100%) 
Participants full / part complete follow-up: n=250 (85.0%)  
Participants withdrawn / potential withdrawals: n=18 (6.1%) 
Lost to follow-up: n = 26 (8.9%) 
- Unable to contact: n = 22 
- Participant moved: n = 1 
- Participant choice: n = 3 
Fig. 1 The HELP study
CONSORT diagram. HELP
CONSORT diagram.
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Primary and secondary outcomes (measured at the
patient level)
The primary outcome was maternal BMI at 12 months
postpartum. Secondary outcomes were antenatal and birth
complications (routine data), pregnancy weight gain, waist
circumference and waist-hip ratio, child weight centile,
mental health (General Health Questionnaire-12), physical
activity (7 Day PAR), diet (DINE), alcohol (AUDIT-C),
quality of life (EQ-5D), costs, smoking and breast feeding
behaviours (study developed questions) [20].
Sample size
An individually randomised trial would require 143 women
per group to detect a difference in BMI of 1.5 kg/m2, based
on an assumed SD of 4.5, a two-sided alpha of 5% and 80%
power (equivalent to a moderate effect size of 0.333). This
difference is in line with weight loss observed in trials
including obese women after 1-year follow-up [25]. An
intracluster correlation coefficient (ICC) of 0.02 was
assumed, which with twenty antenatal units recruiting an
average of 20 women gives a variance inflation factor of 1.4
(ICC= 0.02) and a required sample of 400. To allow for
loss to follow-up of 30% we planned to recruit 570 women.
Centre randomisation
The first ten sites were randomised as a block using the
optimal allocation method of assignment so that interven-
tion training and recruitment could begin [26, 27]. Rando-
misation of units was optimally balanced according to
geographical location and patient list size, proportion of
women with BMI ≥ 30 kg/m2 and ethnic mix. This was
carried out by a statistician independent of the trial. How-
ever, because of delays in setting up the remaining sites, the
randomisation method was changed to minimisation (using
the balance from the first ten sites) [28, 29]. Subsequent
units were randomised as approvals were obtained, main-
taining balance for the same four balancing variables using
minimisation with the addition of an 80% weighted random
component. For these units, the trial statistician based in the
Cardiff Centre for Trials Research carried out the
randomisation blind to the unit’s identity.
Statistical analysis
The primary analysis was by intention to treat (ITT),
comparing BMI (kg/m2) between study groups at 12 months
postpartum. For all primary and secondary outcomes,
multilevel linear models fitted cluster (maternity unit) and
individual effects. BMI data were log-transformed for all
regression analyses and baseline BMI as well as variables
used to balance the randomisation included as covariates.
The intervention effect for BMI was therefore interpreted as
the percentage difference between groups. Two-level
logistic models were used for categorical outcomes. The
impact of individual demographic factors as well as theo-
retical mediators on the intervention effect was investigated
(self-efficacy, social support, intrinsic motivation and self-
regulation) [20]. Pre-specified subgroups were examined
formally using interaction terms for parity, social class,
ethnicity and smoking status. A complier average causal
effect (CACE) analysis investigated the effect of interven-
tion group attendance on the primary outcome. The influ-
ence of missing data was assessed using multiple
imputation under a missing at random assumption. Sensi-
tivity analyses were examined for departures towards
missing not at random. All primary and secondary analyses
were performed in IBM SPSS Statistics 20 and STATA
v13, imputation was performed in STATA v13.
Economic analysis
A within-trial analysis assessed between group differences
in costs against differences in quality-adjusted life years
(QALY) derived from the EQ-5D responses from the per-
spective of the UK NHS and Personal Social Services and
following appropriate guidelines [30–33]. Total costs
included the intervention, healthcare costs and patients’ out-
of-pocket expenses. Reported healthcare resource use and
out-of-pocket expenses covered the 3 months prior to each
follow-up and were proportionally adjusted to the appro-
priate time interval. Unit costs for health professional visits
and labour costs for intervention midwives were obtained
from the Personal Social Services Research Unit [34]. Unit
costs for Accident and Emergency department attendance
and hospitalization were obtained from NHS reference costs
[35]. A multilevel linear model estimated the effect of the
HELP intervention on costs at each follow-up, after
adjusting for baseline costs and other characteristics. Inter-
vention costs were also calculated for the intervention arm.
EQ5D responses were combined using the UK value set
to compute health utilities [36]. A multilevel model esti-
mated utilities at each follow-up, controlling for character-
istics and baseline utilities. The area under the curve (AUC)
for the within-trial period (17 months) was calculated by
adding the quality-adjusted time between follow-up points.
A multiple imputation analysis followed methodological
guidelines [37]. Missing at random (MAR) was assumed
and chained equations were used to predict missing values.
Costs and QALYs were estimated for each imputation
sample to obtain the distribution of the estimates [38].
The incremental net monetary benefit was computed as
INMB= ΔQALY× λ− ΔCost. Where λ is the threshold for
the monetary value of a QALY, ΔCost is the incremental cost
S. A. Simpson et al.
between the HELP intervention and the control, and ΔQALY
is the incremental QALY. Two policy-relevant thresholds
were used, λ= £20,000, £30,000, as per NICE reference case
[39]. Probabilistic analysis was performed and the probability
of dominance, i.e. the likelihood of an alternative being less
costly and more effective, was also computed.
Code availability and data deposition
The study datasets and code used to generate the results is
available for IBM SPSS Statistics v23 and StataCorp LP
Stata/IC 13.1 upon request from the author.
Process evaluation
A mixed methods process evaluation was conducted in line
with MRC guidance [39]. Detailed methods are published
in our protocol paper. Adherence, contamination and fide-
lity data are reported here. Intervention group observations
to assess fidelity were completed independently by two
researchers. Observations were completed twice per site
using a structured observation checklist covering key
aspects of the intervention [20]. Semi-structured qualitative
interviews with participants and focus group with inter-




1511 women were screened and 605 were recruited and
randomised, with seven subsequently excluded due to non-
eligibility. 464/598 (78%) provided primary outcome data
at both baseline and 12 months postpartum (Fig. 1). A
higher proportion of control participants completed the
study (85% versus 70% in intervention arm): this was
explored further in the missing data analysis.
Process evaluation results
When withdrawals are excluded, almost half of the women
(49.4%) attended between 26 and 100% of all available
sessions (23.4% did not attend any sessions, 27.2% attended
fewer than 25%, 14.6% attended 26–50%, 26.4% attended
between 51 and 75% and 8.4% attended over 76% ses-
sions). On average participants attended 34% of sessions
before birth and 25% of the session after birth. Across the
units, the proportion of those never attending varied from 6
to 48%. Agreement between raters assessing fidelity was
84.5% across all sites and all observations. The intervention
was generally delivered with good fidelity. Key intervention
components including diet, goal setting, self-monitoring
and motivation were discussed in 75–100% of observed
sessions. The follow-up telephone calls were completed as
planned for just over two-thirds of intervention participants,
with the other third uncontactable after repeated attempts.
However, there was evidence that the physical activity
component was poorly implemented, where step targets
were only discussed about half the time, with a range of
15.8–76.6% in observed sessions. In addition, few women
regularly kept the diaries of physical activity and only 14
provided complete diary data. Qualitative data provided no
evidence of contamination across arms.
Baseline summary data for participants and units
Table 1 shows that at baseline, the recruited sample had a
mean BMI 37.2 (kg/m2), the BMI was higher in the inter-
vention group. Baseline BMI was included in the primary
analysis to adjust for any imbalance. The two arms were
reasonably balanced on other baseline characteristics.
Summary data for clusters (maternity units), confirmed
that good balance was achieved overall for the factors used
to balance the randomisation: geographic region, ethnic
mix, BMI and size of centre. Baseline demographic char-
acteristics by centre indicated balance according to
allocation.
Baseline demographic characteristics were similar in
women with complete data for the primary outcome at
baseline compared to those with missing primary outcome
data at final follow-up. However, those with complete data
were more likely to be in the managerial and professional
socio-economic group (44.9% versus 32.4%) and less likely
to be current smokers (10.7% versus 20.7%).
Primary and secondary outcomes
Among participants with complete data at baseline and
follow-up, the mean (SD) BMI at 12 months postpartum
was 36.0 kg/m2 (5.2) in the control group, which was lower
than in the intervention group BMI (37.5 kg/m2 (6.7). This
is similar to the baseline difference between arms. In the
primary trial analysis (Table 2), the intervention effect was
0.02 (95% CI −0.04 to 0.01). As BMI was log-transformed
for regression analysis the intervention effect was inter-
preted in percentage terms, as a 2% difference in favour of
the intervention arm, which was not statistically significant.
The ICC was 0.044, indicating 4.4% of the variance in final
BMI is accounted for by variations between centre. When
additional covariates were added to the final model
(women’s age, previous weight loss history variables and
mental health) the results were unchanged. Variations in
numbers with BMI at baseline and follow up are due to
missing covariate data.
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Pre-specified subgroup analyses of the primary outcome
relating to social class, parity and ethnicity demonstrated no
differences in the intervention effect between each sub-
group. The smoking status interaction term just reached
conventional statistical significance indicating a slightly
stronger favourable effect of the intervention in participants
who were current smokers at baseline (smoker treatment
effect 95% CI: −0.05 (−0.10, 0), p= 0.05). These results,
as for any exploratory subgroup analyses, should be inter-
preted with caution.
With regards to secondary outcomes (Table 3), there was
no significant difference between groups for any of the
weight-related outcomes. However, the proportion reporting
attendance at other weight management groups at
12 months follow-up was significantly higher in the inter-
vention group. There were also significant differences
between groups on diet and alcohol consumption. The
DINE results indicated that the intervention group had an
improved healthy eating score and a higher fibre score
compared to the control group at 12-month follow-up. The
AUDIT-C results indicate the intervention group had sig-
nificantly lower levels of risky drinking at 12 months
postpartum than the control group, even after adjusting for
their higher baseline levels.
Table 1 Demographic balance
of control and intervention arms
at baseline for those recruited to
the study.
Control Intervention Overall
n Mean (SD) or
median [IQR] or
n (%)






BMI (kg/m2) 294 36.5 (4.9) 304 37.9 (5.7) 37.2 (5.4)
BMI category 294 304
30–34.9 128 (43.5%) 118 (38.8%) 246 (41.1%)
>=35 166 (56.5%) 186 (61.2%) 352 (58.9%)
Weight (kg) 294 99.1 (15.2) 304 102.4 (17.3) 100.8 (16.4)
Age (years) 294 28.8 (5.5) 304 29.1 (5.1) 28.9 (5.3)
Gestation (weeks) 293 16.1 (2.4) 304 15.3 (2.7) 15.7 (2.6)
Parity 292 1 [1] 303 1 [2] 1 [2]
Current smoker (n% Yes) 294 39 (13.3%) 304 40 (13.2%) 79 (13.2%)
Cigarettes per daya 39 8.8 (6.5) 39 8.7 (4.5) 8.8 (5.6)
Marital status (%) 292 304
Married/cohabiting 230 (78.8%) 257 (84.5%) 487 (81.7%)
Single/divorced/widowed 62 (21.2%) 47 (15.5%) 109 (18.3%)
Education (% in group) 291 297
First degree or higher 61 (21.0%) 69 (23.2%) 130 (22.1%)
Stayed in school till 18 95 (32.6%) 80 (26.9%) 175 (29.8%)




Managerial, professional 93 (38.1%) 148 (46.2%) 209 (42.2%)
Intermediate, small
employers




62 (25.4%) 60 (23.9%) 122 (24.6%)
Ethnicity (% in group) 292 302
White 260 (89.0%) 272 (90.0%) 532 (89.5%)
Asian 13 (4.5%) 15 (5.0%) 28 (4.7%)
Black 14 (4.8%) 9 (3.0%) 23 (3.9%)
Mixed/other 5 (1.7%) 6 (2.0%) 11 (1.9%)
Attempting to lose weight
before this pregnancy (%
yes)
294 237 (80.6%) 302 253 (83.8%) 490 (82.2%)
GHQ 293 114 (38.9%) 302 135 (44.7%) 249 (41.8%)
aBased on smokers.
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Clinical outcomes included birth weight, pregnancy
and birth complications. Gestational age at birth (weeks)
in the intervention group was slightly lower than in the
control group (difference −0.49 (−0.86 to −0.11);
p= 0.01). The only other significant difference in clinical
outcomes was the Apgar scores at 1 min (0.31 (0.10 to
0.97); p= 0.01) where the percentage in the normal range
was slightly higher in the control group (51.5% vs
48.5%). All other clinical findings were comparable for
these two groups.
Sensitivity analyses
Analyses excluding women who were pregnant again at
12 months or had recently had a further baby (n= 20
women; 11 control and 9 intervention) did not differ from
the primary analyses (−0.02 (−0.04 to 0.01); p= 0.20).
Addition of women who telephone self reported their
weight did not alter the intervention effect in comparison
with the primary analysis (−0.02 (−0.04 to 0.01);
p= 0.16).
A complier average causal effect (CACE) analysis
explored the effect of intervention group attendance. Ana-
lyses used the number of sessions attended by the partici-
pants, or a binary variable dichotomised at a cut off of at
least seven sessions for intervention ‘dose’ (55.9% attended
<7 sessions and 44.1% at least 7 sessions). By using ran-
domisation as the instrumental variable, the efficacy
per session (the incremental effects of each session) atten-
ded was assessed. The adjusted results indicate that there
was a small efficacy per intervention group session effect on
BMI in favour of the intervention which was not significant
(−0.001 (−0.003 to 0); p= 0.11). Moreover, those
attending at least seven sessions showed slightly greater loss
in BMI but this was not statistically significant in the binary
model (−0.024 (−0.053 to 0.005; p= 0.11). This analysis
was unadjusted for unit effects and is therefore averaged
over all units.
Exploratory mediation analyses did not find any sig-
nificant mediators of the intervention effect and repeated
measures analyses did not alter the primary result.
Missing data analysis
To further investigate the possible effect of missing
data at follow-up, multiple imputation was carried out
under the assumption of missing at random (MAR). A
sensitivity analysis was then undertaken in order to
assess the effects of departures from the MAR
assumption. The result from the combined imputed
datasets (N = 30) did not differ from the complete case
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Economic analysis
The percentage of missing values for the intervention arm
varied between 0.3%, for utilities at baseline, and 33.9%,
for costs at 12 m follow-up. Missing information at each
follow up was statistically significantly (all p-values lower
than 0.02) lower for the control group, with highest missing
rate at 22.4%, for costs at 6 weeks postpartum. The cost-
effectiveness analysis is shown in Table 4. The total cost per
patient (including healthcare, out-of-pocket and intervention
costs) was −£404.50 lower for the intervention arm,
although that figure is not statistically significant (p-value
Table 3 Secondary outcomes.












BMI and weight related outcomes
BMI 36 weeks 259 36.3 (4.5) 39.2 (4.5) 208 38.2 (6.1) 40.6 (6.0) 0.008 0.002 (−0.009 to 0.014)$ 0.977$
BMI 6 weeks 247 36.3 (4.6) 36.1 (4.5) 220 38.1 (5.8) 37.5 (5.6) 0.001 (−0.10 to 0.014)$
BMI 6 months 245 36.2 (4.6) 36.3 (5.0) 211 38.2 (6.1) 37.9 (6.4) 0.001 (−0.011 to 0.013)$
Weight at
12 mb (kg)
245 98.4 (15.0) 98.0 (16.3) 203 103.1 (18.2) 101.6 (20.3) 0.043 −0.02 (−0.04, 0.01) 0.17
Waist/hip ratio
12 m








206 75 (36.4%) 85 (41.3%) 173 72 (41.6%) 81 (46.8%) 0.113 *1.14 (0.64, 2.06) 0.65
Exceeding
IOMc guidance
259 n/a 90 (34.7%) 208 n/a 66 (31.7%) 0 *0.89 (0.59, 1.36) 0.60
Lost 5% body
weight at 6 m




243 170 (72.6%) 75 (32.1%) 194 155 (77.9%) 100 (51.5%) 0.100 *2.13 (1.03, 4.38) 0.04
Other secondary outcomes
AUDIT-Ce,f 242 23 (9.5%) 107 (44.2%) 202 39 (19.3%) 66 (32.7%) 0.017 *0.45 (0.27, 0.74) 0.002
DINE (HE)g 248 2.4 (13.7) 3.6 (13.1) 207 1.9 (13.5) 5.9 (13.8) 0.025 3.08 (0.16, 6.00) 0.04
DINE (FIBRE) 248 28.4 (12.1) 25.6 (12.0) 207 29.2 (11.7) 28.8 (11.8) 0.007 3.22 (1.07, 5.37) 0.01
DINE (FAT) 248 26.0 (10.6) 21.9 (8.4) 207 27.2 (10.7) 23.0 (8.0) 0.027 0.44 (−1.42, 2.30) 0.64
DINE (UFAT) 248 8.0 (1.8) 8.0 (2.3) 207 8.1 (2.0) 7.7 (2.1) 0.000 −0.38 (−0.78, 0.03) 0.07
DINE (FV) 248 5.2 (2.6) 4.8 (2.1) 207 4.9 (2.6) 4.9 (2.6) 0.008 0.37 (−0.09, 0.82) 0.12
7 day PAR (log
transformed)h
243 88.5 (38.0) 76.8 (24.8) 195 81.0 (27.1) 76.6 (29.9) 0.292 −0.01 (−0.17, 0.14) 0.88
aIntra-cluster correlation.
bAlso adjusted for baseline height and weight (log-transformed data).
cInstitute of Medicine.
dNot including the study intervention.
eProportion reporting higher risk drinking.
fThere was an error in this questionnaire version that meant the validated score could not be calculated. This score is the total sum of the three
AUDIT-C questions converted into a binary outcome 0–3 low risk and 4–6 high risk.
gHigher score indicates healthier diet for healthy eating, fibre, fruit and vegetables, lower is healthier for FAT and UFAT.
hIntervention effect is interpreted as percentage difference.
*Odds ratio.
$Treatment by time effect from repeated measures analysis.
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0.134; CI: −933.1 to 124.1). Also, non-significant QALY
losses are estimated for the intervention arm (−0.0024;
p-value= 0.926; CI: −0.0522, 0.0475). On average, the
INMB is higher for the intervention arm at both λ= 20,000
and λ= 30,000; not statistically significant according to
95% CIs. The probability of dominance is higher for the
intervention compared to the control arm. The cost-
effectiveness acceptability curve (CEAC) in Fig. 2, shows
that the probability of being cost-effective is higher for the
intervention group at any threshold below £100,000 per
QALY.
Adverse events
A total of 1114 adverse events were reported (502 inter-
vention and 612 control), 245 of these were categorised as
serious adverse events (114 intervention and 131 control),
none were categorised as related to the intervention.
Discussion
Although at the 12-month follow-up we observed a lower
mean BMI in the intervention arm compared to the control
arm (a 2% adjusted difference in BMI), this difference was
not statistically significant. The intervention was not
effective in reducing BMI at follow-up. The intervention
had positive impacts on two secondary outcomes related to
diet, where the intervention group reported healthier eating
and lower levels of risky drinking at 12 months postpartum.
The EQ5D results showed no health utility improvements
for the intervention arm and there were no statistically
significant lower total costs estimated for the
intervention arm.
Comparison with other studies
Meta-analyses indicate that lifestyle interventions targeting
diet and physical activity can impact on GWG and post-
partum weight loss [13–15, 40, 41]. Although not statisti-
cally significant, the difference between arms in BMI (in the
current study) indicated some benefit of the intervention
(2% difference) at 12 months. Studies have shown that
weight loss of 2–5 kg can reduce the risk of diabetes and
cardiovascular risk [41–43]. Although some trials testing
lifestyle interventions have shown positive effects on GWG
[14, 44–46], like other studies we did not find any statisti-
cally significant differences between arms [47, 48]. In the
Table 4 Economic evaluation
results: costs per patient (£),
QALYs per patient, and
incremental analysis.
Alternatives HELP intervention Usual care Incremental
Mean [95% CIa] Mean [95% CI] Mean [95% CI]










INMBc (λ= 20,000) 357.3 [−832.6, 1547.2]











a95% confidence intervals computed from bootstrapped standard errors.
bQuality-adjusted life years.
cINMB: incremental net monetary benefit. Dominance refers to the probability of the alternative being both
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Fig. 2 Cost-effectiveness acceptability curve. Multiple imputation.
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current trial women improved their diet without losing a
significant amount of weight, however, this dietary
improvement could potentially be beneficial to the devel-
opment of the foetus. The higher rates of healthy eating
found in the intervention arm have been noted in other trials
of lifestyle interventions [45, 49], in some cases also
without a substantial impact on weight [47]. The economic
evaluation findings are consistent with previous studies in
that there is no strong evidence that diet-and-physical
activity-based interventions in pregnancy are more effective
than standard care [50–53]. Total costs per patient
(including healthcare, out-of-pocket and intervention costs)
in the intervention arm, however, had an 89% probability of
being lower than standard care hence future studies should
ensure the full spectrum of costs are measured to explore
this finding further.
The lack of a significant difference in BMI between arms
may be partially explained by the fact that women in both
groups were quite intensively followed up and there may
have been an impact of this measurement. Also in com-
parison with other studies, the women in the control group
appear to have done well in terms of GWG within IOM
guidance. Vinter et al. [46] found that 46.6% of women in
the control group exceeded the recommendations, and Dodd
et al. [49] found 42% were above these recommendations,
which is much higher than the 34.7% in the controls in the
present study. This may have made it more difficult to
detect differences due to our intervention.
Two other issues may explain the non-significant impact
of the intervention on BMI, these are the issues with
adherence to the intervention in terms of group attendance,
as well as the poor implementation of key aspects of the
physical activity component. This may have had an impact
on the effectiveness of the intervention, given that diet and
physical activity together are most effective for weight loss
and this was a key aspect of the intervention [14, 16]. Also
since some of the groups had very few women attending at
different stages of the study, this may have had a negative
impact on social support, a key mechanism of the inter-
vention. Additional support may also be required in the
postpartum period, as current evidence in weight loss stu-
dies indicates that ongoing support is more likely to lead to
effective weight loss [21, 54].
Strengths and weaknesses
To the authors’ knowledge, this is the first adequately
powered RCT including cost-effectiveness, to assess the
impact of a lifestyle intervention (for pregnant women with
obesity), which starts during pregnancy and continues into
the postpartum, on weight at 12 months postpartum. The
intervention was designed and piloted following best prac-
tice [55] and it was generally well-received both by the
healthcare professionals and the women in the study. The
study has several strengths including an intervention which
was developed based on relevant theory and evidence of
effective behaviour change techniques, an objectively
measured primary outcome of clinical significance and good
retention rates. A large sample of women from across the
UK were recruited and although the ICC was higher than
we had anticipated for the primary outcome, more partici-
pants were recruited than originally planned and retention
was higher, so the study was adequately powered. Maternity
units across areas of higher deprivation as well as more
affluent areas were recruited. The study tested an inter-
vention which had it proved effective could have been
rolled out across the NHS, using the same delivery model as
current antenatal classes.
There are a number of limitations, one of those was
compliance; around a third of the intervention arm did not
attend the group or engage with midwife phone calls.
This is not unusual for weight loss interventions where
attrition varies from 10 to 80% [56]. However, the
intervention was quite intensive which likely impacted on
engagement. Although we recruited units from across
England and Wales with different levels of area depri-
vation, the sample of women recruited were pre-
dominantly white with low representation of different
ethnic minorities. This was a pragmatic trial and it was
not possible to blind participants or recruiters to centre
allocation which could have led to bias in those recruited.
There may be some evidence of this as women had higher
baseline mean BMI in the intervention group, although
we adjusted for baseline BMI. We do not feel that this
resulted in systematic bias and allocation concealment
was adequate for a cluster design. Drop out was less than
expected overall but was higher in the intervention arm
than in the control arm. This effect has previously been
noted [45]. Imputation was carried out to investigate
possible bias and adjust for this, but the conclusions
remained unchanged.
Conclusions
This intervention was not effective in reducing BMI at
12 months postpartum. It did lead to positive impacts on
two secondary outcomes; healthy eating and risky drinking.
If these reductions in risky drinking and improved diet were
sustained they could reduce longer-term risks related to
non-communicable diseases. The intervention made a
positive contribution but was not enough on its own to
produce a sustained effect on BMI. Ongoing support in the
postpartum period may be needed to impact on weight loss
in the longer term. Pregnancy is a time of significant change
in women’s lives and is a potentially important ‘teachable
moment’ in which to influence long-term obesity risk.
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Identifying effective interventions that could provide sup-
port to women in the postpartum period and beyond is a
vital step in tackling obesity. Benefits to public health could
be far-reaching including lower healthcare costs and
improvements in women’s physical and psychological
health. Future work should explore the factors influencing
attendance to try and develop more equitable services that
maximize outcomes for all women. In addition, further
high-quality trials of interventions are needed which take
into account the complex context of weight management in
pregnancy and the postpartum. Future interventions will
likely need to tackle the problem at multiple levels to be
effective.
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